Novo Nordisk Inc. et al v. Mylan Institutional LLC

Plaintiff: Novo Nordisk Inc. and Novo Nordisk A/S
Defendant: Mylan Institutional LLC
Case Number: 1:2019cv01551
Filed: August 20, 2019
Court: US District Court for the District of Delaware
Nature of Suit: Patent - Abbreviated New Drug Application(ANDA)
Cause of Action: 35:271
Jury Demanded By: None

Docket Report

This docket was last retrieved on August 21, 2019. A more recent docket listing may be available from PACER.

Date Filed Document Text
August 21, 2019 Filing 6 SUMMONS Returned Executed by Novo Nordisk Inc., Novo Nordisk A/S. Mylan Institutional LLC served on 8/21/2019, answer due 9/11/2019. (Blumenfeld, Jack)
August 21, 2019 Summons Issued with Magistrate Consent Notice attached as to Mylan Institutional LLC on 8/21/2019. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (mal)
August 20, 2019 Filing 5 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Novo Nordisk US Holdings, Inc. for Novo Nordisk A/S, Novo Nordisk Inc. filed by Novo Nordisk A/S, Novo Nordisk Inc.. (mal)
August 20, 2019 Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,268,343 B1; 7,762,994 B2; 8,114,833 B2; 8,579,869 B2; 8,846,618 B2; 9,265,893 B2; RE41,956 E. (mal)
August 20, 2019 Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 07/09/2019. Date of Expiration of Patent: See Attached.Thirty Month Stay Deadline: 1/9/2022. (mal)
August 20, 2019 Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (mal)
August 20, 2019 Filing 1 COMPLAINT filed against Mylan Institutional LLC - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2712502.) - filed by Novo Nordisk Inc., Novo Nordisk A/S. (Attachments: #1 Exhibit A-G, #2 Civil Cover Sheet)(mal)

Access additional case information on PACER

Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.

Access this case on the Delaware District Court's Electronic Court Filings (ECF) System

Search for this case: Novo Nordisk Inc. et al v. Mylan Institutional LLC
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Web [ Legal Web | Google | Bing | Yahoo | Ask ]
Plaintiff: Novo Nordisk Inc.
Represented By: Brian P. Egan
Represented By: Jack B. Blumenfeld
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Legal Web | Google | Bing | Yahoo | Ask ]
Plaintiff: Novo Nordisk A/S
Represented By: Brian P. Egan
Represented By: Jack B. Blumenfeld
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: Mylan Institutional LLC
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Legal Web | Google | Bing | Yahoo | Ask ]

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.


Why Is My Information Online?